{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014883","form_type":"8-K","ticker":"CDT","cik":"0001896212","company_name":"CDT Equity Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.129818+00:00","generated_at":"2026-06-03T22:25:11.163596+00:00","sec_items":["4.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Conduit Pharmaceuticals restates 2023 quarterly results on legal expense miscapitalization; non-reliance","bullets":["Previously issued unaudited financials for Q1, Q2, Q3 2023 should no longer be relied upon due to misclassification of legal expenses.","Legal expenses related to business combination and PIPE financing were expensed but should have been capitalized, reducing quarterly expenses by $493k, $402k, $639k respectively.","Restatement adjustments understated net income (loss), understated prepaid expenses, and overstated additional paid-in capital; deemed material individually and in aggregate.","Company will incorporate the corrections in footnotes of its upcoming 10-K annual report; discussed with auditor Marcum LLP.","Marcum LLP has provided a letter agreeing with the statements in this 8-K, attached as Exhibit 7.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014883","json":"https://secwatch.observer/filing/0001493152-24-014883.json","markdown":"https://secwatch.observer/filing/0001493152-24-014883.md","text":"https://secwatch.observer/filing/0001493152-24-014883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224014883/0001493152-24-014883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224014883/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:25:11.163596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e51061beaf3cfd29636e285dc9ab5991e0a50c4","claim":"CDT Equity Inc. reported that prior financial statements should not be relied upon.","evidence_excerpt":"the Company’s previously issued unaudited financial statements, and notes related thereto, for the Subject Periods (as defined below) should no longer be relied upon due to the advised restatements described below pertaining to the accounting treatment of certain legal expenses previously incurred.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224014883/0001493152-24-014883-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"non reliance"},{"label":"Auditor","value":"Marcum LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}